Antitumor activity and antioxidant status of Symplocos racemosa Roxb against Ehrlich ascites carcinoma in swiss albino mice

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Volumn 1, Issue 3, 2010, Pages 306-314

  Vijayabaskaran, M ^a   Badkhal, Amol K ^a   Babu, G ^a   Sivakumar, P ^a   Perumal, P ^a   Sivakumar, T ^b   Sampathkumar, R ^c   Jayakar, B ^d  

^a JKK Nataraja College of Pharmacy   (India)

^b NANDHA COLLEGE OF PHARMACY   (India)

^c UNIVERSITY OF ZAWIA   (Libyan Arab Jamahiriya)

^d VINAYAKA MISSION S RESEARCH FOUNDATION DEEMED TO BE UNIVERSITY   (India)

Author keywords

Antioxidant; Antitumor activity; Ehrlich ascites carcinoma; Hematological parameter; Symplocos racemosa

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CATALASE; PLANT EXTRACT; SYMPLOCOS RACEMOSA EXTRACT; UNCLASSIFIED DRUG; VINCRISTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG SAFETY; EHRLICH ASCITES TUMOR; HEMATOLOGICAL PARAMETERS; LIFESPAN; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; SHRUB; SURVIVAL TIME; SYMPLOCOS RACEMOSA; TREATMENT DURATION; TUMOR VOLUME;

MURINAE; MUS; SYMPLOCOS RACEMOSA;

EID: 79952517202     PISSN: None     EISSN: 09758585     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Abdullaev F. Exp Biology and Medicine 2002; 227(1): 20-25.
2. Patil S, Jolly CI, Narayanan S. Indian Drugs 2003; 40(6):328-332.
3. Kirtikar KR, Basu BD. Indian Medicinal Plants. International Book Distributors and Bookseller,Dehradun, Vol. IV, 1998, pp. 2738-2739
4. Rajkapoor B, Jaykar B, Murugesh N. Indian J Pharmacol 2004; 36 (1): 38-40
5. Rajeshwar Y, Gupta M, Mazumder UK. Iran J Pharmacol. Ther 2005; 4: 46-53.
6. Litchfield JT, Wilcoxon F. J Pharmacol Exp Ther 1949; 96:99-133
7. Gupta M, Mazumdar UK, Sambathkumar R, Sivakumar T. Acta Pharmacol Sin 2004; 25(8): 1070-1076
8. Ramkrishna Y, Manohar AL, Mamata P, Shreekant KG. Indian Drugs 1984; 21:173-185
9. Gothoskar SV, Ranadive KJ. Indian J Exp Biol 1971; 9(3):372-375
10. Joharapurkar AA, Zambad SP, Wanjari MM, Umathe SN. Indian J Pharmacology 2003; 35: 232-236.
11. Okhawa H, Ohishi, N, Yagi K. Anal Biochem 1979; 95:351-358.
12. Aebi H. Methods of Enzymatic Analysis. Academic Press, Newyork, Vol.3: 1974, pp.673-684
13. Jocelyn PC. Biochem J1962; 85:480-85.
14. th ed.1961; pp.326
15. De Kakali, Roy K, Saha A, Sengupta C. Acta Poloniae Pharmaceutica 2004; 61(l):77-86
16. Jagetia GC, Rao SK. Biol Pharm Bull 2006;29(3): 460-466
17. Ray A, Chaudhary SR, Majumdar B, Bandyopadhyay S. Indian J Clin Biochem 2002;17(2):44-51
18. Hullatti KK, Uma D Murthy, Shrinath BR. Pharmacognosy Magazine, 2006;2(8): 220-223
19. Prasad SB,Giri A. Indian J Exp Biol 1994;32:155-162
20. Clarkson BD,Burchenal JH. Prog Clin Cancer 1965; 1:625-629
21. Price VE,Greenfield RE. Adv Cancer Res 1958;5:199-200
22. Hogland HC. Semin Oncol 1982; 9:95-102
23. Fenninger LD,Mider GB.Adv Cancer Res 1954;2:229-253
24. Valenzuela A.Life Sci 1990; 48:301-309
25. Neilsen F, Mikkelsen BB, Neilsen JB, Andersen HR, Grandjean P. Clin Chemist 1997; 47:1209-1214.